您的浏览器禁用了JavaScript（一种计算机语言，用以实现您与网页的交互），请解除该禁用，或者联系我们。[德意志银行]：HENGRUI MEDICINE(600276)：AT EARLY STAGE OF ANOTHER GROWTH CYCLE; INITIATING WITH BUY - 发现报告
回到首页AI搜索发现报告发现数据专题报告研选报告定制报告VIP权益
热门搜索：
新能源车AIGCChatgpt大模型新质生产力低空经济
当前位置：首页/其他报告/报告详情/

HENGRUI MEDICINE(600276)：AT EARLY STAGE OF ANOTHER GROWTH CYCLE; INITIATING WITH BUY

2015-10-07Jack H、Linc Yi德意志银行在***
HENGRUI MEDICINE(600276)：AT EARLY STAGE OF ANOTHER GROWTH CYCLE; INITIATING WITH BUY

点击免费查看完整报告

你可能感兴趣

hot

At the centre stage of growth;initiating with Buy

德意志银行2016-09-26
hot

Hengrui Medicine(恒瑞医药(600276))：Expecting healthy export growth in 2016

医药生物
德意志银行2016-02-02
hot

An evident winner in China’s infant stage LCC market? Initiating with Buy

德意志银行2016-12-02
hot

Inspur International Limited（0596.HK）Key takeaways from 1H 2018 results presentation and one~on~one discussion；at an early stage of the re~rating cycle.

中银国际2018-08-21
hot

HK Market Strategy Bi-weekly(Vol.16,2015)：Take the shot at the early stage of rebound

招商证券2015-09-14